Image-based Chronic Kidney Disease Diagnosis Using 2D Convolutional
Neural Networks in the Context of a Comprehensive Artificial
Intelligence-Driven Healthcare System
FRANK EDUGHOM EKPAR1,2,3
1Founder, Scholars University Ltd, Port Harcourt, NIGERIA
2Department of Computer Engineering, Rivers State University, Port Harcourt, NIGERIA
3Department of Computer Engineering, Topfaith University, Mkpatak, NIGERIA
Abstract: - Reports published by the World Health Organization (WHO) indicate that noncommunicable
diseases (NCDs) including chronic kidney disease (CKD) are among the top ten causes of mortality worldwide.
Accurate and early diagnosis of chronic kidney disease could save lives, ameliorate deleterious effects and
dramatically improve quality of life. This paper presents a system that harnesses convolutional neural networks
(CNNs) that could be incorporated into a comprehensive artificial intelligence (AI)-driven healthcare system
for the automated diagnosis of chronic kidney disease. Utilizing publicly available image datasets featuring
images representing normal kidney states, cysts, tumors and kidney stones split into training and validation
samples, the system achieves an accuracy approximating 97% on the training and validation datasets.
Key-Words: - Chronic Kidney Disease (CKD), Artificial Intelligence (AI), Deep Learning (DL), Convolutional
Neural Network (CNN), Two-dimensional (2D) Convolutional Neural Network (2D CNN), Healthcare System,
CT Image
Received: March 29, 2024. Revised: Agust 25, 2024. Accepted: September 29, 2024. Published: November 14, 2024.
1 Introduction
In addition to the high mortality rate measured in
millions per annum globally, chronic kidney disease
exerts an enormous toll in terms of lost economic
opportunities and physical and psychological
suffering [1] [2]. Accurate and early diagnosis
could be leveraged to create more efficacious
therapies and management strategies and
consequently save lives and enhance quality of life
indicators and achieve improved health outcomes
across board. Ekpar [3] introduced a comprehensive
artificial intelligence (AI)-driven healthcare system
with a modular design that could accommodate AI
models for the diagnosis of chronic kidney disease.
Previous work has been reported in the literature
featuring the utilization of AI models for the
diagnosis of a wide range of health conditions
including chronic kidney disease [4] [29] with
varying degrees of success.
This paper presents a system built on
convolutional neural networks (CNNs) trained to
classify diagnostic images. The system employs
publicly available diagnostic CT-radiography
images indicating the normal kidney state as well as
the presence of kidney cysts, stones and tumors [4]
with the possibility of incorporating the resulting
system into a comprehensive artificial intelligence
(AI)-driven healthcare system.
Further integration of genetic and environmental
factors could enhance the utility of the system with
more accurate representations of the circumstances
of the participants. Additionally, locally aggregated
datasets could augment and/or replace the publicly
available datasets currently harnessed to reduce bias
and promote the global relevance of the decisions
that could be supported by the inferences drawn
from the system.
The modular design makes the system amenable
to the incorporation of new modules for the
diagnosis, prediction and management of additional
health conditions and the enhancement of existing
modules on the basis of fresh data.
MOLECULAR SCIENCES AND APPLICATIONS
DOI: 10.37394/232023.2024.4.13
Frank Edughom Ekpar
E-ISSN: 2732-9992
135
Volume 4, 2024
2 Materials and Methods
This section outlines how participants could be
recruited for experiments on the basis of ethical
clearances obtained as well as the methods pursued
for the actualization of the system.
2.1 Participant Recruitment
Participants willingly took part in the studies
focused on developing a comprehensive AI-driven
healthcare system, each providing informed consent
for their participation.
2.2 Ethical Clearance
The Health Research Ethics Committee at the
Institute of Biomedical Research, University of
Uyo, approved the studies ethically. All research
complied with relevant ethical and regulatory
standards, and publicly available data was utilized in
line with the licensing terms established by its
creators.
2.3 Methodology
Publicly accessible healthcare datasets can be
improved by integrating data collected from local
experiments and data collection initiatives, which
can be used to train AI models for actionable
predictions based on new data. Sources of public
healthcare datasets include the Centers for Disease
Control, the University of California Irvine Machine
Learning Repository, the American Epilepsy
Society, and Kaggle.
Incorporating local data enhances robustness,
minimizes bias, and fosters inclusivity and global
relevance.
One innovative approach in this project is
combining diagnostic measurements, including
electrocardiographic results, from local experiments
with EEG data from both traditional and novel
advanced three-dimensional multilayer EEG
systems.
For local data collection efforts, the research
has received ethical approval from the relevant
ethics committees overseeing the regions where the
experiments take place. Furthermore, partnerships
have been established with licensed medical doctors
experienced in these areas, who have direct access
to patients and other clinicians in the community.
These doctors will collaborate with the project to
provide anonymized clinical measurements for
validating the AI models.
The trained AI models could be integrated into
a comprehensive healthcare system that offers
clinical decision support to medical practitioners
and facilitates the generation of brain-computer
interfaces (BCIs). This support will be based on
actionable insights derived from new clinical data
provided by medical professionals, aiding in the
early detection, diagnosis, treatment, prediction, and
prevention of various conditions, including diabetes
mellitus, heart disease, stroke, autism, and epilepsy.
This project is dedicated to advancing open
science, reproducibility, and collaboration. As such,
the generated data will be made available in public
repositories like GitHub and Kaggle.
3 Systemic Solution
3.1 System Design and Implementation
The comprehensive healthcare system outlined in
this paper features a modular design, with each
condition (such as chronic kidney disease, heart
disease, diabetes mellitus, stroke, epilepsy, and
autism) assigned to its own module. This structure
allows for future applicability in diagnosing and
predicting additional conditions and facilitates
efficient updates to existing modules with new data.
Brain-computer interface (BCI) modules, such as
those using the motor imagery paradigm, can
process EEG data to generate actionable commands
and other appropriate responses.
The system includes guidelines for adapting
traditional EEG systems to innovative three-
dimensional multilayer EEG systems. These novel
systems, developed by Ekpar [30] [31], are based
on a conceptual framework that employs
approximations of carefully chosen representative
features of bio-signal sources for characterizing or
manipulating the underlying biological systems.
For each module, robust AI models are
developed and trained using appropriately formatted
data collected as described. These AI models can
integrate genetic, environmental, lifestyle, and other
relevant factors to provide more accurate
representations of participants' circumstances.
MOLECULAR SCIENCES AND APPLICATIONS
DOI: 10.37394/232023.2024.4.13
Frank Edughom Ekpar
E-ISSN: 2732-9992
136
Volume 4, 2024
Fig. 1 depicts the design of the system with a
simplified graphical representation of the modules
and other key components of the system.
Fig. 1: System Schematic Design Diagram for the Comprehensive AI-Driven Healthcare Solution and Brain
Computer Interface System. The New Conditions component represents additional health conditions that can be
incorporated into the solution via new modules.
The AI models are developed using the four distinct
approaches listed below. Note that in addition to the
four distinct approaches highlighted herein,
additional approaches (possibly incorporating
modern topological and algebraic methods) could be
adopted and the results (in terms of performance
metrics) compared and contrasted for possible
integration of the models into the system.
1. Direct Use of Large Language Models
(LLMs): Leveraging large language models
(LLMs) like GPT-4 as inference engines,
utilizing the collected data formatted as
multidimensional input vectors. This
process may include fine-tuning the LLM.
2. Prompt Engineering with LLMs:
Applying prompt engineering techniques to
LLMs like Bard and GPT-4 (and their
future iterations) to outline a series of steps
for constructing the AI-based system. The
proposed steps are executed using the
creator's deep expertise in AI, neural
networks, and deep learning, along with
programming in Python and using tools like
TensorFlow, Keras, and other machine
learning and visualization libraries such as
Scikit-learn and Matplotlib.
3. Automated Model Generation: Creating
specific AI models by harnessing the
features of LLMs like Bard and GPT-4
MOLECULAR SCIENCES AND APPLICATIONS
DOI: 10.37394/232023.2024.4.13
Frank Edughom Ekpar
E-ISSN: 2732-9992
137
Volume 4, 2024
through an automated model generation
pipeline.
4. Direct Synthesis of AI Architecture:
Synthesizing a suitable AI architecture
based on the creator's substantial experience
in AI, neural networks, and deep learning,
employing Python, TensorFlow, Keras, and
additional machine learning and
visualization tools.
All processes and tools used in developing the
solution are thoroughly documented to ensure
smooth transfer and reuse of the system. The
performance of the generated AI models is
evaluated and compared using metrics such as
specificity and sensitivity, assessing their suitability
for the challenges presented.
3.2 Convolutional Neural Network
Architecture and Data Processing
Custom-synthesized two-dimensional (2D)
convolutional neural networks (CNNs) were
harnessed in the AI models of the system and
leveraged for multiclass (four-class: normal, cyst,
tumor, stone) image classification for the purpose of
diagnosis of chronic kidney disease from CT-
radiography. Figure 2 illustrates a generalized
depiction of the CNN architecture. The CNNs were
realized via toolsets provided by the TensorFlow
framework coupled with the Keras API in the
Python programming language [32] - [33].
Fig. 2: Generalized Illustration of the Convolutional Neural Network (CNN) Architecture.
The 2D CNN comprised three separate 2D
convolutional blocks each coupled with a 2D max
pooling layer. ReLU activation was utilized. The
first 2D convolutional layer featured 16 filters, the
second featured 32 filters while the third layer
featured 64 filters. The kernel size used was 3. A
preprocessing data augmentation layer
implementing rotation of the images by 18 degrees
was added to prevent overfitting. Z-normalization
was applied via the batch normalization function.
Before flattening and connection to the fully
connected layers, a dropout layer with a dropout rate
of 0.2 was added to the AI model.
Public CT-radiography image datasets [4] were
utilized in training and validation of the AI model.
The dataset comprised a total of 12,446 clinically
validated images spread across four distinct classes
representing normal kidney function (5,077 images),
presence of kidney cyst (3,709 images), presence of
kidney stone (1,377 images) and presence of kidney
tumor (2,283 images). First, the images were
shuffled to ensure balance and then split into
training and validation datasets with the training
dataset being allocated 80% of the data and the
validation dataset being allocated 20% of the data.
Furthermore, a new data partition containing 20% of
the data was generated after random shuffling for
evaluation of the CNN after training and validation.
The images were resized to a width of 180 pixels
and a height of 180 pixels before processing.
Processing proceeded with a batch size of 32.
Figure 3 shows a randomly selected sample of
images from the dataset representing all four
classes: Normal, Cyst, Tumor and Stone.
MOLECULAR SCIENCES AND APPLICATIONS
DOI: 10.37394/232023.2024.4.13
Frank Edughom Ekpar
E-ISSN: 2732-9992
138
Volume 4, 2024
Fig. 3: Sample Images from the Dataset Representing All Four Classes: Normal, Cyst, Stone and Tumor.
3.3 Data Availability
The data utilized in this study are available from
Kaggle at
https://www.kaggle.com/datasets/nazmul0087/ct-kidney-
dataset-normal-cyst-tumor-and-stone.
4 Results
The CNN was trained on the training dataset (9957
images or 80% of the original 12,446 images) and
validated on the validation dataset (2,489 images or
20% of the original 12,446 images) over 10 epochs.
Sparse categorical cross entropy loss function was
utilized. The AI model was optimized via the Adam
Optimizer [34] [35] with a learning rate of 0.001.
Figure 4 illustrates the performance of the AI model
on the training and validation datasets.
As can be seen from Fig. 4, the performance of
the CNN improved over the training and validation
cycles until an accuracy of approximately 97% was
achieved for the training and validation datasets.
Evaluation of the resulting AI model after training
and validation on a randomly selected test dataset
comprising 20% of the original data yielded
comparable results.
MOLECULAR SCIENCES AND APPLICATIONS
DOI: 10.37394/232023.2024.4.13
Frank Edughom Ekpar
E-ISSN: 2732-9992
139
Volume 4, 2024
Fig. 4: Performance of the Convolutional Neural Network (CNN) on Training and Validation Datasets.
Implementing the comprehensive AI system
outlined here will provide valuable insights for
clinical decision-making, ultimately saving lives and
enhancing quality of life. It aims to alleviate the
economic, social, psychological, and physical
burdens associated with conditions that can be
predicted, potentially prevented, detected early,
diagnosed, and managed more effectively.
Participating medical doctors and their
colleagues can generate Electronic Health Records
(EHR) that include clinical diagnostic
measurements and EEG data. EEG data may also be
collected during experiments with Brain-Computer
Interfaces (BCIs). This data is gathered in
compliance with ethical approvals and is
anonymized prior to being published in publicly
accessible repositories alongside academic research
articles.
5 Conclusion
Convolutional neural networks were harnessed for
the classification of medical images representing
kidney states indicating normal function, the
presence of cysts, the presence of tumors as well as
the presence of kidney stones. The resulting AI
model could be integrated into a chronic kidney
disease diagnosis module within the context of a
comprehensive AI-driven healthcare system. The
system exhibited excellent performance, achieving
an accuracy approximating 97% for the training and
validation datasets. Adopting the comprehensive AI-
powered healthcare system in resource-limited
settings such as low- and middle-income countries
(LMIC) with low doctor-to-patient ratios and
limited healthcare funding could permit a single
medical doctor or healthcare worker to serve up to
ten or more times the usual number of patients,
effectively increasing the doctor-to-patient ratio and
dramatically improving health outcomes and saving
lives without significant additional investments.
Generally, the high accuracy of the system
encourages adoption and utilization of the system
for improved health outcomes in both developed
and developing countries and regions. In the future,
the system could incorporate genetic and lifestyle
factors for a more accurate reflection of the patient’s
circumstances and to facilitate recommendations for
lifestyle modifications that could help prevent
disease.
MOLECULAR SCIENCES AND APPLICATIONS
DOI: 10.37394/232023.2024.4.13
Frank Edughom Ekpar
E-ISSN: 2732-9992
140
Volume 4, 2024
References:
[1] World Health Organization (WHO) - Top 10 Causes
of Death: https://www.who.int/news-room/fact-
sheets/detail/the-top-10-causes-of-death. Retrieved
(2024).
[2] World Health Organization (WHO)
Noncommunicable Diseases:
https://www.who.int/news-room/fact-
sheets/detail/noncommunicable-diseases. Retrieved
(2024).
[3] Ekpar, F. E. A Comprehensive Artificial
Intelligence-Driven Healthcare System, European
Journal of Electrical Engineering and Computer
Science, 8(3), Article 617. (2024).
[4] Islam, N. M., Hassan, M., Hossain, M. K.,
Alam, M. G. R., Uddin, M. Z., Soylu, A. Vision
transformer and explainable transfer learning
models for autodetection of kidney cyst, stone
and tumor from CT-radiography, Scientific
Reports, 12: 11440. (2022).
[5] Nomura, A., Noguchi, M., Kometani, M.,
Furukawa, K., Yoneda, T. Artificial Intelligence
in Current Diabetes Management and
Prediction, Curr Diab Rep. 21(12):61 (2021).
[6] Kumar, Y., Koul, A., Singla, R., Ijaz, M. F.
Artificial intelligence in disease diagnosis: a
systematic literature review, synthesizing
framework and future research agenda, Journal
of Ambient Intelligence and Humanized
Computing 14:8459–8486 (2023).
[7] Ansari, S., Shafi, I., Ansari, A., Ahmad, J.,
Shah, S. I. Diagnosis of liver disease induced by
hepatitis virus using artificial neural network,
IEEE Int Multitopic.
https://doi.org/10.1109/INMIC.2011.6151515
(2011).
[8] Guo, H., Cao, S., Zhou, C., Wu, X., Zou, Y.
Predicting Essential Genes of Alzheimer
Disease based on Module Partition and Gravity-
like Method in Heterogeneous Network, WSEAS
Transactions on Applied and Theoretical
Mechanics, Vol. 17, pp. 158-165. (2022).
[9] Battineni, G., Sagaro, G. G., Chinatalapudi, N.,
Amenta, F. Applications of machine learning
predictive models in the chronic disease
diagnosis, J Personal Med.
https://doi.org/10.3390/jpm10020021 (2020).
[10] Abdar, M., Yen, N., Hung, J. Improving the
diagnosis of liver disease using multilayer
perceptron neural network and boosted decision
tree, J Med Biol Eng 38:953–965 (2018).
[11] Chaikijurajai, T., Laffin, L., Tang, W. Artificial
intelligence and hypertension: recent advances
and future outlook, Am J Hypertens 33:967–974
(2020).
[12] Fujita, S., Hagiwara, A., Otsuka, Y., Hori, M.,
Takei, N., Hwang, K. P., Irie, R., Andica, C.,
Kamagata, K., Akashi, T., Kumamaru, K. K.,
Suzuki, M., Wada, A., Abe, O., Aoki, S. Deep
Learning Approach for Generating MRA
Images From 3D Quantitative Synthetic MRI
Without Additional Scans, Invest Radiol
55:249–256 (2020).
[13] Ahuja, R., Sharma, S. C. Exploring Feature
Selection and Classification Algorithms for
Cardiac Arrythmia Disease Prediction, WSEAS
Transactions on Biology and Biomedicine, Vol.
19, pp. 168-175. (2022).
[14] Juarez-Chambi, R. M., Kut, C., Rico-Jimenez, J.
J., Chaichana, L. K., Xi, J., Campos-Delgado,
D. U., Rodriguez, F. J., Quinones-Hinojosa, A.,
Li, X., Jo, J. A. AI-Assisted In Situ Detection of
Human Glioma Infiltration Using a Novel
Computational Method for Optical Coherence
Tomography, Clin Cancer Res 25(21):6329–
6338 (2019).
[15] Nashif, S., Raihan, R., Islam, R., Imam, M. H.
Heart Disease Detection by Using Machine
Learning Algorithms and a Real-Time
Cardiovascular Health Monitoring System,
World Journal of Engineering and Technology
Vol 6, No. 4 (2018).
[16] Chen, P. H. C., Gadepalli, K., MacDonald, R.,
Liu, Kadowaki, S., Nagpal, K., Kohlberger, T.,
Dean, J., Corrado, G. S., Hipp, J. D., Mermel,
C. H., Stumpe, M. C. An augmented reality
microscope with real time artificial intelligence
integration for cancer diagnosis, Nat Med
25:1453–1457 (2019).
[17] Gouda, W., Yasin, R. COVID-19 disease: CT
Pneumonia Analysis prototype by using
artificial intelligence, predicting the disease
severity, Egypt J Radiol Nucl Med 51(1):196
(2020).
[18] Han, Y., Han, Z., Wu, J., Yu, Y., Gao, S., Hua,
D., Yang, A. Artificial Intelligence
Recommendation System of Cancer
Rehabilitation Scheme Based on IoT
Technology, IEEE Access 8:44924–44935
(2020).
[19] Zeynu, S., Patil, S. Prediction of Chronic
Kidney Disease Using Data Mining Feature
Selection and Ensemble Method, WSEAS
Transactions on Information Science and
Applications, Vol. 15, pp. 168-176. (2018).
[20] Chui, C. S., Lee, N. P., Adeoye, J., Thomson,
P., Choi, S. W. Machine learning and treatment
MOLECULAR SCIENCES AND APPLICATIONS
DOI: 10.37394/232023.2024.4.13
Frank Edughom Ekpar
E-ISSN: 2732-9992
141
Volume 4, 2024
outcome prediction for oral cancer, J Oral
Pathol Med 49(10):977–985 (2020).
[21] Koshimizu, H., Kojima, R., Okuno, Y. Future
possibilities for artificial intelligence in the
practical management of hypertension,
Hypertens Res 43:1327–1337 (2020).
[22] Kather, J. N., Pearson, A. T., Halama, N., Jäger,
D., Krause, J., Loosen, S. H., Marx, A., Boor,
P., Tacke, F., Neumann, U. P., Grabsch, H. I.,
Yoshikawa, T., Brenner, H., Chang-Claude, J.,
Hoffmeister, M., Trautwein, C., Luedde, T.
Deep learning microsatellite instability directly
from histology in gastrointestinal cancer, Nat
Med 25:1054–1056 (2019).
[23] Sreeja, M. U., Supriya, M. H. A Deep
Convolutional Model for Heart Disease
Prediction based on ECG Data with Explainable
AI, WSEAS Transactions on Information
Science and Applications, Vol. 20, pp. 254-264.
(2023).
[24] Kwon, J. M., Jeon, K. H., Kim, H. M., Kim, M.
J., Lim, S. M., Kim, K. H., Song, P. S., Park, J.,
Choi, R. K., Oh, B. H. Comparing the
performance of artificial intelligence and
conventional diagnosis criteria for detecting left
ventricular hypertrophy using
electrocardiography, EP Europace 22(3):412–
419 (2020).
[25] Khan, M. A. An IoT Framework for Heart
Disease Prediction Based on MDCNN
Classifier, IEEE Access 8:34717–34727 (2020).
[26] Bora, N., Gutta, S., Hadaegh, A. Using machine
learning to Predict Heart Disease, WSEAS
Transactions on Biology and Biomedicine, Vol.
19, pp. 1-9. (2022).
[27] Oikonomou, E. K., Williams, M. C., Kotanidis,
C. P., Desai, M. Y., Marwan, M.,
Antonopoulos, A. S., Thomas, K. E., Thomas,
S., Akoumianakis, I., Fan, L. M., Kesavan,
S., Herdman, L., Alashi, A., Centeno, E. H.,
Lyasheva, M., Griffin, B. P., Flamm, S. D.,
Shirodaria, C. Sabharwal, N., Kelion, A.,
Dweck, M. R., Van Beek, E. J. R., Deanfield, J.,
Hopewell, J. C., Neubauer, S., Channon, K.
M., Achenbach, S., Newby, D. E., Antoniades,
C. A novel machine learning-derived
radiotranscriptomic signature of perivascular fat
improves cardiac risk prediction using coronary
CT angiography, Eur Heart J 40(43):3529–
3543 (2019).
[28] Sabottke, C. F., Spieler, B. M. The Effect of
Image Resolution on Deep Learning in
Radiography, Radiology: Artificial Intelligence
Vol. 2. No. 1, 2:e190015 (2020).
[29] Mohammed, A. N., Albagul, A., Ahmad, M. M.
Automated Alzheimer’s Disease Diagnosis
using Convolutional Neural Networks and
Magnetic Resonance Imaging, WSEAS
Transactions on Signal Processing, Vol. 19, pp.
118-127. (2023).
[30] Ekpar, F. E. System for Nature-Inspired Signal
Processing: Principles and Practice, European
Journal of Electrical Engineering and
Computer Science, 3(6), pp. 1-10, (2019).
[31] Ekpar, F. E. A Novel Three-dimensional
Multilayer Electroencephalography Paradigm,
Fortune Journal of Health Sciences, 7(3).
(2024).
[32] Abadi, M., Barham, P., Chen, J., Chen, Z.,
Davis, A., Dean, J., Devin, M., Ghemawat, S.,
Irving, G., Isard, M., Kudlur, M., Levenberg, J.,
Monga, R., Moore, S., Murray, D. G., Steiner,
B., Tucker, P., Vasudevan, V., Warden, P.,
Wicke, M., Yu, Y., Zheng, X. TensorFlow: A
System for Large Scale Machine Learning,
Proceedings of the 12th USENIX Symposium on
Operating Systems Design and Implementation
(OSDI ’16). (2016).
[33] Pang, B., Nijkamp, E., Wu, Y. N. Deep
Learning With TensorFlow: A Review, Journal
of Educational and Behavioral Statistics. Vol.
45, Iss. 2. (2019).
[34] Kingma, D. P., Ba, J. L. Adam: A Method
for Stochastic Optimization, International
Conference on Learning Representations
(ICLR) (2015).
[35] Zhang, Z. Improved Adam Optimizer for
Deep Neural Networks, IEEE/ACM 26th
International Symposium on Quality of
Service (IWQoS) (2018).
MOLECULAR SCIENCES AND APPLICATIONS
DOI: 10.37394/232023.2024.4.13
Frank Edughom Ekpar
E-ISSN: 2732-9992
142
Volume 4, 2024
Contribution of Individual Authors to the
Creation of a Scientific Article (Ghostwriting
Policy)
Frank Edughom Ekpar took charge of all aspects of
this work including conceptualization, design,
implementation, experiment design, execution and
administration, data gathering (including from
public sources) and data analysis and processing as
well as manuscript preparation.
Conflict of Interest
The author has no conflicts of interest to declare that
are relevant to the content of this article.
Creative Commons Attribution License 4.0
(Attribution 4.0 International, CC BY 4.0)
This article is published under the terms of the
Creative Commons Attribution License 4.0
https://creativecommons.org/licenses/by/4.0/deed.en
_US
Sources of Funding for Research Presented in a
Scientific Article or Scientific Article Itself
No funding was received for conducting this study.
MOLECULAR SCIENCES AND APPLICATIONS
DOI: 10.37394/232023.2024.4.13
Frank Edughom Ekpar
E-ISSN: 2732-9992
143
Volume 4, 2024